Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions

Lyne Jossé1, Ricardo Marchante, Jo Zenthon

  • 1Kent Fungal Group, School of Biosciences, University of Kent, Canterbury, UK.

Prion
|March 28, 2012
PubMed

Insights

Yeast models reveal how prion protein (PrP) sequences, particularly the octarepeat region, can drive amyloid formation. This study highlights yeast

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Yeast, particularly Saccharomyces cerevisiae, serves as a model organism for studying protein misfolding diseases.
  • Misfolded proteins, such as amyloids, are implicated in neurodegenerative conditions.
  • Understanding the mechanisms of protein misfolding is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of specific prion protein (PrP) sequences in amyloid formation using a yeast-based system.
  • To identify sequence and structural features of PrP critical for its conversion into an infectious form.
  • To explore the utility of yeast as a model for studying protein misfolding disorders.

Main Methods:

  • Expression of fusion proteins in yeast (Saccharomyces cerevisiae) comprising Sup35 and various regions of mouse PrP.
  • Utilizing yeast-based assays to detect and analyze protein misfolding events.
  • Focusing on the contribution of the mouse octarepeat region in PrP-induced amyloidogenesis.

Main Results:

  • Prion protein (PrP) sequences can direct the formation of non-transmissible amyloids in yeast.
  • The mouse octarepeat region of PrP plays a significant role in this amyloid formation.
  • Demonstrated the capacity of yeast models to study specific aspects of PrP misfolding.

Conclusions:

  • Yeast models are valuable tools for dissecting the molecular basis of protein misfolding disorders.
  • Specific PrP regions, like the octarepeat, can induce amyloid formation independently of the infectious prion form.
  • The study underscores both the strengths and limitations of using yeast for modeling human protein misfolding diseases.

Related Concept Videos